These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23906202)

  • 1. Model for hepatitis C virus transmissions.
    Elbasha EH
    Math Biosci Eng; 2013 Aug; 10(4):1045-65. PubMed ID: 23906202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global stability of equilibria in a two-sex HPV vaccination model.
    Elbasha EH
    Bull Math Biol; 2008 Apr; 70(3):894-909. PubMed ID: 17999117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamical analysis on a chronic hepatitis C virus infection model with immune response.
    Li J; Men K; Yang Y; Li D
    J Theor Biol; 2015 Jan; 365():337-46. PubMed ID: 25451526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematically modelling the spread of hepatitis C in injecting drug users.
    Corson S; Greenhalgh D; Hutchinson S
    Math Med Biol; 2012 Sep; 29(3):205-30. PubMed ID: 21900152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global analysis of a mathematical model for Hepatitis C virus transmissions.
    Shi R; Cui Y
    Virus Res; 2016 Jun; 217():8-17. PubMed ID: 26940946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the transmission dynamics and control of the novel 2009 swine influenza (H1N1) pandemic.
    Sharomi O; Podder CN; Gumel AB; Mahmud SM; Rubinstein E
    Bull Math Biol; 2011 Mar; 73(3):515-48. PubMed ID: 20379852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal control of HCV transmission under liquoring.
    Shah NH; Shukla N; Satia MH; Thakkar FA
    J Theor Biol; 2019 Mar; 465():27-33. PubMed ID: 30615882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mathematical treatment of AIDS and condom use.
    Greenhalgh D; Doyle M; Lewis F
    IMA J Math Appl Med Biol; 2001 Sep; 18(3):225-62. PubMed ID: 11817744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical analysis of a two strain HIV/AIDS model with antiretroviral treatment.
    Bhunu CP; Garira W; Magombedze G
    Acta Biotheor; 2009 Sep; 57(3):361-81. PubMed ID: 19357968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for influenza with vaccination and antiviral treatment.
    Arino J; Brauer F; van den Driessche P; Watmough J; Wu J
    J Theor Biol; 2008 Jul; 253(1):118-30. PubMed ID: 18402981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic hepatitis C infection--eradication of the virus].
    Ben Ari Z
    Harefuah; 2014 Jul; 153(7):392-3, 433. PubMed ID: 25189028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of a deterministic and stochastic model for hepatitis C with an isolation stage.
    Imran M; Hassan M; Dur-E-Ahmad M; Khan A
    J Biol Dyn; 2013; 7():276-301. PubMed ID: 24303906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics analysis of a multi-strain cholera model with an imperfect vaccine.
    Safi MA; Melesse DY; Gumel AB
    Bull Math Biol; 2013 Jul; 75(7):1104-37. PubMed ID: 23636819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An age-structured within-host HIV-1 infection model with virus-to-cell and cell-to-cell transmissions.
    Xu R; Tian X; Zhang S
    J Biol Dyn; 2018 Dec; 12(1):89-117. PubMed ID: 29173134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemic dynamics on semi-directed complex networks.
    Zhang X; Sun GQ; Zhu YX; Ma J; Jin Z
    Math Biosci; 2013 Dec; 246(2):242-51. PubMed ID: 24140877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of DAA therapy in hepatitis C treatment - an impulsive control approach.
    Chatterjee AN; Basir FA; Takeuchi Y
    Math Biosci Eng; 2021 Jan; 18(2):1450-1464. PubMed ID: 33757193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of backward bifurcation in a model of hepatitis B and C viruses.
    Qesmi R; Wu J; Wu J; Heffernan JM
    Math Biosci; 2010 Apr; 224(2):118-25. PubMed ID: 20085774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are statins a viable option for the treatment of infections with the hepatitis C virus?
    Verpaalen B; Neyts J; Delang L
    Antiviral Res; 2014 May; 105():92-9. PubMed ID: 24613180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings.
    Dore GJ; Freeman AJ; Law M; Kaldor JM
    Antivir Ther; 2003 Oct; 8(5):365-72. PubMed ID: 14640382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic hepatitis C].
    Grammatikos G; Sarrazin C
    Dtsch Med Wochenschr; 2010 Dec; 135(50):2525-34; quiz 2535-8. PubMed ID: 21140330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.